Slow and Steady Wins the Race: 25 Years Developing the GLP-1 Receptor as an Effective Target for Weight Loss. Kumar N, D'Alessio DA. J Clin Endocrinol Metab 2022;107:2148-2153.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kumar N, D'Alessio DA. Slow and Steady Wins the Race: 25 Years Developing the GLP-1 Receptor as an Effective Target for Weight Loss. J Clin Endocrinol Metab 2022;107:2148-2153.
PMID: 35536590